A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis

NCT01945086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: Ustekinumab
DRUG: Placebo
OTHER: Concomitant topical medications for atopic dermatitis

Sponsor

Janssen Pharmaceutical K.K.